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Background: Autism spectrum disorders (ASDs) are a group of neurodevelopmental conditions with a demonstrated
genetic etiology. Rare (<1% frequency) copy number variations (CNVs) account for a proportion of the genetic events
involved, but the contribution of these events in non-European ASD populations has not been well studied. Here, we
report on rare CNVs detected in a cohort of individuals with ASD of Han Chinese background.
Methods: DNA samples were obtained from 104 ASD probands and their parents who were recruited from Harbin,
China. Samples were genotyped on the Affymetrix CytoScan HD platform. Rare CNVs were identified by comparing
data with 873 technology-matched controls from Ontario and 1,235 additional population controls of Han Chinese
ethnicity.
Results: Of the probands, 8.6% had at least 1 de novo CNV (overlapping the GIGYF2, SPRY1, 16p13.3, 16p11.2, 17p13.3-
17p13.2, DMD, and NAP1L6 genes/loci). Rare inherited CNVs affected other plausible neurodevelopmental candidate
genes including GRID2, LINGO2, and SLC39A12. A 24-kb duplication was also identified at YWHAE, a gene previously
implicated in ASD and other developmental disorders. This duplication is observed at a similar frequency in cases and
in population controls and is likely a benign Asian-specific copy number polymorphism.
Conclusions: Our findings help define genomic features relevant to ASD in the Han Chinese and emphasize the
importance of using ancestry-matched controls in medical genetic interpretations.
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Autism spectrum disorders (ASDs) are characterized by
impairments in communication, social interaction, as
well as repetitive and restrictive behaviors. Individuals
with ASDs also frequently demonstrate other medical
challenges such as intellectual disability and seizures,
and the ASD phenotype is recognized in over 100 differ-
ent medical genetic disorders [1]. Underlying genetic risk
factors, particularly rare penetrant genic copy number
variations (CNVs), are thought to explain approximately* Correspondence: stephen.scherer@sickkids.ca
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article, unless otherwise stated.5–10% of the disorder depending on the cohort examined.
However, no single candidate genetic locus has been im-
plicated in more than 1% of ASD cases and hundreds of
candidate genes have been identified [1].
Most CNV studies in ASD have focused on individuals
of European ancestry [2-4], but studies describing the
genetic architecture in other populations are also re-
quired, particularly as clinical microarray testing con-
tinues to be adopted as the standard of care across
medical genetic labs worldwide [5]. Outside North
America and Western Europe, the reported prevalence
of ASD varies from the approximately 1% usually noted
[6]. In China, the first ASD cases were not detected until
the early 1980s and a meta-analysis estimated the rate of
ASD in newborns as 11.8 per 10,000 [7].
Genetic studies of ASD in Han Chinese individuals have
been presented primarily as case reports or associationtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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phisms (SNPs) previously identified in individuals with
ASD of European ancestry [8]. So far, however, there has
been a dearth of published studies of rare CNVs in
Chinese autism cohorts. Moreover, previous CNV studies
in the general Asian population have shown substantial
differences in terms of location and frequency of some
CNVs [9], necessitating our ongoing work to examine the




ASD-affected individuals and their families were referred
to the Children Development and Behavior Research
Center (CDBRC) at Harbin Medical University, China,
by their community physician between January 2007 and
June 2011. Proband diagnosis and study inclusion cri-
teria were completed as previously described [8]. The
Autism Behavior Checklist (ABC) and Childhood Aut-
ism Rating Scale (CARS) were used for diagnosis. We
report on 104 consecutive cases with an ASD diagnosis
made by two psychiatrists at the CDBRC. Subsequently,
DNA was also obtained from the parents of these ASD
individuals. Proband participants consisted of 91 males
(87.5%) and 13 females (12.5%). The mean age of the
probands at enrolment was 4.31 ± 1.80 years. The study
was approved by the Ethics Committee at Harbin Med-
ical University and written consent was obtained from
parents.
Genotyping and variant calling
Genotyping was performed on the Affymetrix CytoScan
HD platform (Santa Clara, CA, USA) according to the
manufacturer's specifications. PLINK software was used
to confirm the Han Chinese ethnicity of all individuals
in the study from extracted SNP genotypes (Additional
file 1: Figure S1). Samples from 100 probands and 200
parents passed our quality control metrics including 93
complete trios. CNVs were called via our CNV detection
pipeline (Additional file 1: Figure S2). Population control
datasets used to distinguish rare variants included three
Han Chinese-specific cohorts and one microarray-specific
set of primarily European individuals (see Additional
file 1). For all case and control samples, genotyping and
CNV calling were performed using identical procedures
[10] and CNV data was compared against the Database of
Genomic Variants [11]. Validation methods confirmed
96% (27/28) of the CNVs tested.
Expression analysis
The SuperScript III First-Strand Synthesis SuperMix for
qRT-PCR kit (Life Technologies, Carlsbad, CA, USA)
was used to generate cDNA from RNA extracted from11 tissues and a whole brain sample. Expression analysis
and tissue distribution of CASKIN1 and PKD1 were il-
lustrated using quantitative RT-PCR. The housekeeping
genes MED13 and ACTB were used to normalize the ex-
pression level.
Results
Using a high-resolution CNV genotyping array and a
well-established CNV calling protocol (Additional file 1:
Figure S2), we identified 241 rare CNVs in our probands
(Additional file 1: Table S1). We established that 11 of
the probands from the 93 complete trios (11.8%) carried
a de novo or rare inherited CNV that may contribute to
ASD (Table 1). The CNV profiles of both the ASD cases
and their parents indicated that there is no significant dif-
ference in the overall CNV call rates or the length of CNVs
between these two groups (Additional file 1: Table S2).
De novo variants
Nine de novo CNV events were detected in eight pro-
bands (Table 1). This represents a de novo CNV rate of
8.6% (8/93), similar to that which has been seen previ-
ously in other non-Chinese CNV studies [2-4,12]. In one
female proband (683-3), we discovered a 22-kb deletion
at 2q37.1 overlapping GIGYF2, which lies in a suscepti-
bility locus for familial Parkinson's disease [13]. No ASD
phenotype has been previously associated with variants
affecting this gene.
A 982-kb de novo duplication was uncovered in male
proband 527-3. This duplication overlaps SPRY1, a gene
that regulates fibroblast growth factor signaling which
plays an important role in the patterning and propaga-
tion of cells in the developing brain [14]. There is no
prior evidence of any link between duplications overlap-
ping this gene or SPATA5 and ASD.
A pair of adjacent de novo duplications at 16p13.3 sep-
arated by nearly 1 Mb of two-copy intervening sequence
was uncovered in a 6-year-old female (517-3). To better
assess which genes might be contributing to the pheno-
type, we referred to a recent finding showing that highly
brain-expressed exons have a lower burden of rare mis-
sense variants than more ubiquitously expressed exons
and are targets for penetrant mutations in ASD [15]. We
then checked each of the exons in the genes residing
within the duplications to determine if any of these were
characterized as a ‘brain-critical exon.’ This was the case
for at least one exon in RAB26, PKD1, E4F1, ABCA3,
and CASKIN1 (Additional file 1: Figure S3). We focused
on CASKIN1 and PKD1 due to previous studies indicat-
ing that they may play some role in synaptic scaffolding
and neurodevelopment [16,17]. In these two genes, we
confirmed the presence of a brain-expressed isoform
whose dosage could be impacted by the duplication
(Additional file 1: Figure S3). The 16p13.3 duplication
Table 1 Summary of de novo and rare inherited CNVs of interest in ASD probands
Sample ID Cytoband Coordinates (hg19) Type of CNV Genes affected Inheritance
683-3 (female) 2q37.1 Chr2: 233,651,280-233,673,273 22-kb deletion GIGYF2 De novo
527-3 (male) 4q28.1 Chr4: 124,063,146-125,045,116 982-kb duplication SPRY1, SPATA5 De novo
517-3 (female) 16p13.3 Chr16: 843,861-1,162,728 319-kb duplication 7 genes De novo
16p13.3 Chr16: 2,088,391-2,415,016 327-kb duplication 15 genes De novo
503-3 (male) 16p11.2 Chr16: 28,819,029-29,051,191 232-kb deletion 9 genes De novo
692-3 (male) 17p13.3, 17p13.2 Chr17: 2,455,643-3,449,869 994-kb duplication 16 genes De novo
567-3 (male) Xp21.1 ChrX: 31,805,650-31,959,887 154-kb deletion DMD De novo
611-3 (male) Xp21.1 ChrX: 32,548,066-32,603,018 55-kb deletion DMD De novo
552-3 (male) Xq13.2 ChrX: 72,319,907-72,353,391 33-kb deletion NAP1L6 De novo
694-3 (male) 4q22.2 Chr4: 94,144,621-94,172,410 28-kb deletion GRID2 Maternal
9p21.1 Chr9: 28,491,679-28,630,598 139-kb deletion LINGO2 (intronic) Paternal
511-3 (male) 9p21.1 Chr9: 28,464,218-28,596,286 132-kb deletion LINGO2 Maternal
686-3 (male) 10p12.33 Chr10: 18,240,592-18,313,842 73-kb deletion SLC39A12 Paternal
All CNVs shown above have been confirmed via qPCR or a targeted TaqMan assay, and de novo status and inheritance was verified by testing both parental
samples using these same methods.
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was recently described to be involved in obsessive-
compulsive disorder [18].
A male proband (503-3) was found to carry a 232-kb
de novo microdeletion at 16p11.2. This deletion lies
upstream of the 600-kb ASD-implicated risk locus [1].
Similarly sized deletions have been previously noted in
individuals with obesity and developmental delay
[12,19]. Unlike many of the individuals with similar dele-
tions, this male has a BMI of 18.26, putting him in the
normal range.
A 994-kb duplication of 17p13.3-17p13.2 was uncov-
ered in a 5-year-old autistic male (692-3). Microduplica-
tions have been previously noted at this locus and are
usually associated with developmental delay and fre-
quently with growth issues [20]. This proband has typ-
ical autistic features and no evidence of any growth
problems.
Two unrelated male probands harbor de novo exonic
deletions of the Duchenne Muscular Dystrophy (DMD)
gene. The first case (611-3), a 5-year-old autistic male
presenting with ASD, hypotonia, and progressive motor
impairments including difficulty walking, has a 55-kb
deletion that overlaps exons 14–17. The second proband
(567-3), an autistic 6-year-old male with abnormal
muscular development, has a deletion of 154 kb which
overlaps exons 46–50. In both cases, the deletion is pre-
dicted to cause a frameshift leading to a premature stop
and loss of dystrophin. In males, such mutations are pre-
dicted to result in DMD. Studies have shown a higher
incidence of ASD in boys with DMD, possibly because
of a secondary synaptic role for the protein [21].
A 33.5-kb deletion at Xq13.2 has also been noted in
male case 552-3. This deletion overlaps the NAP1L6nucleosome assembly protein. There are no published
reports of deletions affecting this gene.
Rare inherited variants
We identified a 27.8-kb loss of two exons of GRID2 in a
4-year-old male (694-3). GRID2 encodes a glutamate re-
ceptor channel subunit and mutations within GRID2
have been associated with ASD [2]. Our proband in-
herits the mutation from his mother who has a diagnosis
of intellectual disability. His maternal grandfather and a
maternal cousin also have intellectual disability, but no
DNA was available to test the segregation of this variant
in these individuals.
A 73-kb deletion affecting SLC39A12 was found in a 6-
year-old male proband (686-3). All but the last exon of the
gene was deleted in the proband and his unaffected father.
A recent study suggests that this zinc transporter stimu-
lates neurite outgrowth during neurodevelopment [22].
Finally, we identified a male proband (511-3) with a
maternally inherited deletion of one exon of LINGO2.
The gene has been previously associated with adult-
onset neurodegenerative disorders and has been impli-
cated as an ASD risk gene [23]. A second male proband
(694-3) in our study also harbors an intronic CNV
within this gene, but its potential effect on gene expres-
sion and any possible contribution to phenotype were
not possible to ascertain.
Population-specific CNV polymorphisms
We have also identified a population-specific CNV poly-
morphism in YWHAE, a gene previously speculated to
have a role in ASD [20]. Here, we identified a 24-kb du-
plication (chr17: 1,235,975-1,259,833) overlapping the
last exon of this gene in one proband and his mother.
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sians in our Ontario population controls. However, we
identified similar duplications in two unrelated parents
of other probands in this Han Chinese cohort (Figure 1).
We attempted fine-mapping of the breakpoints in the
four different samples carrying the rearrangement and
found that both the 3′ and 5′ ends consistently map to
the same regions, suggesting that the CNVs likely repre-
sent the same ancestral event. We were unable to deter-
mine the precise sites of the breakpoints due to complex
sequence elements located in the region. Subsequently,
we assessed the frequency of this event in the Chinese
population and found that 11/1,235 (0.9%) of the Han
Chinese population controls carried a microduplication
at this locus. Using a TaqMan Copy Number Assay for a
probe located within the breakpoints of the microdupli-
cation, we found duplications in 3/260 additional Han
Chinese controls. In all, approximately 1% of Han Chinese
individuals have this duplication, regardless of ASD status.
We notice no statistically significant difference between
the frequency of this variant in cases versus controls
(p = 1.000 using a two-tailed Fisher's exact test).
Discussion
Our data adds to the growing number of CNV studies in
autism, all of which are critical for accurate interpret-
ation of post- and pre-natal testing being performed or
contemplated in the clinical genetic setting [5,24]. We
have confirmed the important contribution of de novo
and rare inherited CNVs in ASD. Though many of the
genes and loci that have been identified in this study
have been previously detected in European individuals,Figure 1 Genomic location of YWHAE duplications. The locations of the
overlapping the 3′ end of YWHAE locus are shown. We have also identified
samples run on different arrays). Three additional duplications in a second
screening using a quantitative assay (the site of the TaqMan Copy Numberpopulation-specific variants overlapping ASD candidate
genes were identified in cases and Han Chinese popula-
tion controls. This reaffirms the need to account for an-
cestry for the most accurate interpretation of clinical
microarray data. We anticipate that as CNV studies be-
come routine in other ASD populations, we will discover
additional examples of population-specific CNVs, which
are overlapping ASD candidate genes, but are non-
pathogenic [25].
There was no difference with respect to CNV call rate
or the length of CNVs between probands and their par-
ents in our study. However, some groups that have ex-
amined larger cohorts using microarrays [2] or analyzed
smaller types of variation using exome sequencing [26]
have noted a greater enrichment of CNVs in cases when
compared to controls. Additional high-resolution studies
of copy number variation in sufficiently large ASD sam-
ple cohorts will help further clarify potential CNV en-
richment in ASD.
Perhaps our most important finding in this paper is
the identification of the YWHAE CNV that appears to
be a Chinese-specific polymorphism and not an ASD (or
developmental delay)-associated variant. The gene prod-
uct, 14-3-3ε, is a member of the 14-3-3 family of genes
which are highly conserved across species and play an
important role in protein regulation and signal transduc-
tion [27]. Changes in 14-3-3ε dosage have been shown
to alter neuronal migration, thereby impairing proper
neurodevelopment [27]. Several studies have previously
indicated that large duplications or deletions at 17p13.3
affecting this gene are associated with developmental
delay or autism [20,28-30]. The small 24-kb duplicationduplications (represented by blue bars) in the four individuals tested
11 similarly sized duplications in Chinese control samples (from
cohort of Chinese population controls were also found at this locus by
Assay is indicated by the vertical arrow).
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our past work [31] and in clinical cohorts. In light of
these findings, we reevaluated all cases with the 24-kb
duplication and found that they clustered with Asian
individuals when determining ancestry from extracted
SNPs. Unlike the larger CNVs previously identified at
this locus [20,28-30], this small duplication is not
likely to be pathogenic since the frequency of the
event is similar in cases and in population controls.
Our finding with YWHAE provides an example of the
importance of using ancestry-matched controls when
characterizing the clinical relevance of rare variants in
a population.
The prevalence of ASD in mainland China and Western
countries varies considerably [1,6,7]. Our exploratory
study of the role of CNVs in ASD families in China does
not yet provide a genetic explanation for such differences,
and it is more likely that ascertainment bias is involved.
Specifically, it is hypothesized that differences in assess-
ment protocols and cultural expectations (especially with
regard to eye contact and speech) could influence the rec-
ognition of autistic behaviors in ASD individuals with
normal or mildly impaired cognitive functioning [6,7].
Moreover, parental attitudes and a stigma surrounding
neuropsychiatric conditions may also contribute to a reti-
cence towards accepting a potential autism diagnosis [7],
possibly precluding an affected child from being enrolled
in any study of ASD.
The results of this study substantiate the extensive
genetic heterogeneity that is inherent to autism. As a re-
sult, it is of great importance to examine the totality of
genetic variation in order to accurately identify new, po-
tentially causal genes. Though whole-exome and whole-
genome technologies already identify interesting single
nucleotide variants and show promise in detecting in/
dels and copy number changes, microarrays still remain
the gold standard for CNV detection. Future CNV stud-
ies of Han Chinese individuals can build upon the foun-
dation established by this study. Further work in this
population can identify new population-specific variants
that may contribute to ASD, as well as add further sup-
port for the contribution of rare CNVs to ASD.
Conclusions
Our study serves as a pilot to provide initial insight into
the genetic architecture of ASD in the Han Chinese
population. Ongoing genome sequencing experiments
indicate that many more etiologic genetic variants will
be found with higher-resolution technologies [32]. At
this time, CNV testing in the Han Chinese population
using microarrays would be most appropriate usually in
a confirmatory diagnostic setting, at least until larger
cohorts of matched control data become available for
comparisons.Additional file
Additional file 1: Supplemental methods. Figure S1. Ancestry
determination in our ASD cohort. Figure S2. CNV detection workflow.
Figure S3. Identification of brain-critical exons at 16p13.3. Table S1. List
of rare CNVs. Table S2. Summary statistics of stringent CNVs larger than
20 kb.
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